Completed

Phase 4 Study of Scarclinic™ Thin That Treats Surgical Scars.

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

Scarclinic™ Thin

+ Scarclinic™ Normal

Device
Who is being recruted

From 18 to 55 Years
+8 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Treatment Study

Interventional
Study Start: October 2010
See protocol details

Summary

Principal SponsorSeoul National University Hospital
Last updated: April 15, 2013
Sourced from a government-validated database.Claim as a partner

Study start date: October 1, 2010

Actual date on which the first participant was enrolled.

For evaluating the efficacy The investigator check Vancouver Scar Scale at 1 and 3 month after application to evaluate vascularity, pigmentation, elasticity, height, pain and itchiness The participant filled out survey included questions regarding convenience in use at 1 and 3 month after application.

NCT01689857
Principal SponsorSeoul National University Hospital
Last updated: April 15, 2013
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

40 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Treatment Study

These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

From 18 to 55 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Criteria

3 inclusion criteria required to participate
Patient who aged more than 18 years and less 55 years
Patient who has a surgical scar that is not over 3 months after the surgery
Patient who sign informed consent form for the study
5 exclusion criteria prevent from participating
general malaise
history of mental disorders
need wound dressing for exudate
taking anticancer drugs or antiphlogistics or steroid
Show More Criteria

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

2 intervention groups are designated in this study

This study does not include a placebo group 

Treatment Groups

Group I

Experimental
Scarclinic™ Thin

Group II

Active Comparator
Scarclinic™ Normal

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Seoul National Univ. Bundang Hospital

Bundang-gu, South KoreaOpen Seoul National Univ. Bundang Hospital in Google Maps
CompletedOne Study Center